Dedham, MA, United States of America

Madaline Chirica

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 147(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2008)
  • Mountain View, CA (US) (2004 - 2009)
  • Dedham, MA (US) (2010 - 2014)

Company Filing History:


Years Active: 2004-2014

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Madaline Chirica

Introduction

Madaline Chirica is a prominent inventor based in Dedham, MA, known for her significant contributions to the field of biomedical research. With a total of 12 patents to her name, she has made remarkable strides in developing therapeutic solutions for various medical conditions.

Latest Patents

Chirica's latest patents include groundbreaking work on antagonists of IL-23P19 for the treatment of atopic dermatitis. This innovation involves nucleic acids encoding mammalian receptors, including purified receptor proteins and their fragments. Additionally, her patents cover antibodies, both polyclonal and monoclonal, and methods for utilizing these compositions for diagnostic and therapeutic purposes. Another notable patent focuses on mammalian receptor proteins DCRS5, which also includes nucleic acids encoding these receptors and methods of treatment.

Career Highlights

Throughout her career, Madaline Chirica has worked with esteemed organizations such as Schering Corporation and Merck Sharp & Dohme Corporation. Her experience in these companies has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.

Collaborations

Chirica has collaborated with notable professionals in her field, including Robert A. Kastelein and Kevin W. Moore. These partnerships have further enhanced her research and development efforts.

Conclusion

Madaline Chirica's work exemplifies the impact of innovation in the biomedical sector. Her patents and collaborations reflect her dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…